Galanthamine and Non-competitive Inhibitor Binding to ACh-binding Protein: Evidence for a Binding Site on Non-α-subunit Interfaces of Heteromeric Neuronal Nicotinic Receptors

Journal of Molecular Biology

Volumn 369, Issue 4, 2007, Pages 895-901

  Hansen, Scott B ^a,b   Taylor, Palmer ^a  

^a San Diego   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

acetylcholine binding protein; cocaine; galanthamine; nicotinic receptors; non competitive inhibitors

Indexed keywords

ACETYLCHOLINE; BINDING PROTEIN; COCAINE; CYSTEINE; GALANTAMINE; NICOTINIC RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CRYSTAL STRUCTURE; MOLLUSC; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; X RAY CRYSTALLOGRAPHY;

MAMMALIA; MOLLUSCA;

EID: 34248598024     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.03.067     Document Type: Article

References (38)

1. Changeux J.-P. Nicotinic Acetylcholine Receptors: from Molecular Biology to Cognition. 1st edit. (2005), Odile Jacob, New York
2. Pereira E.F., Hilmas C., Santos M.D., Alkondon M., Maelicke A., and Albuquerque E.X. Unconventional ligands and modulators of nicotinic receptors. J. Neurobiol. 53 (2002) 479-500
3. 3H]chlorpromazine. Proc. Natl Acad. Sci. USA 83 (1986) 2719-2723
4. Oberthur W., Muhn P., Baumann H., Lottspeich F., Wittmann-Liebold B., and Hucho F. The reaction site of a non-competitive antagonist in the delta-subunit of the nicotinic acetylcholine receptor. EMBO J. 5 (1986) 1815-1819
5. 3H]meproadifen mustard reacts selectively with alpha-subunit Glu-262. J. Biol. Chem. 267 (1992) 10489-10499
6. Cymes G.D., Ni Y., and Grosman C. Probing ion-channel pores one proton at a time. Nature 438 (2005) 975-980
7. Miyazawa A., Fujiyoshi Y., and Unwin N. Structure and gating mechanism of the acetylcholine receptor pore. Nature 423 (2003) 949-955
8. Akabas M.H., Stauffer D.A., Xu M., and Karlin A. Acetylcholine receptor channel structure probed in cysteine-substitution mutants. Science 258 (1992) 307-310
9. Blanton M.P., Xie Y., Dangott L.J., and Cohen J.B. The steroid promegestone is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid-protein interface. Mol. Pharmacol. 55 (1999) 269-278
10. Gumilar F., Arias H.R., Spitzmaul G., and Bouzat C. Molecular mechanisms of inhibition of nicotinic acetylcholine receptors by tricyclic antidepressants. Neuropharmacology 45 (2003) 964-976
11. Costa V., Nistri A., Cavalli A., and Carloni P. A structural model of agonist binding to the alpha3beta4 neuronal nicotinic receptor. Br. J. Pharmacol. 140 (2003) 921-931
12. Francis M.M., Vazquez R.W., Papke R.L., and Oswald R.E. Subtype-selective inhibition of neuronal nicotinic acetylcholine receptors by cocaine is determined by the alpha4 and beta4 subunits. Mol. Pharmacol. 58 (2000) 109-119
13. Arias H.R., Bhumireddy P., and Bouzat C. Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors. Int. J. Biochem. Cell Biol. 38 (2006) 1254-1276
14. Daly J.W. Nicotinic agonists, antagonists, and modulators from natural sources. Cell Mol. Neurobiol. 25 (2005) 513-552
15. Smit A.B., Syed N.I., Schaap D., van Minnen J., Klumperman J., Kits K.S., et al. A glia-derived acetylcholine-binding protein that modulates synaptic transmission. Nature 411 (2001) 261-268
16. Hansen S.B., Talley T.T., Radic Z., and Taylor P. Structural and ligand recognition characteristics of an acetylcholine-binding protein from Aplysia californica. J. Biol. Chem. 279 (2004) 24197-24202
17. Bouzat C., Gumilar F., Spitzmaul G., Wang H.L., Rayes D., Hansen S.B., et al. Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channel. Nature 430 (2004) 896-900
18. Gao F., Bren N., Burghardt T.P., Hansen S., Henchman R.H., Taylor P., et al. Agonist-mediated conformational changes in acetylcholine-binding protein revealed by simulation and intrinsic tryptophan fluorescence. J. Biol. Chem. 280 (2005) 8443-8451
19. Celie P.H., van Rossum-Fikkert S.E., van Dijk W.J., Brejc K., Smit A.B., and Sixma T.K. Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures. Neuron 41 (2004) 907-914
20. Ernst M., Brauchart D., Boresch S., and Sieghart W. Comparative modeling of GABA(A) receptors: limits, insights, future developments. Neuroscience 119 (2003) 933-943
21. Gao F., Mer G., Tonelli M., Hansen S.B., Burghardt T.P., Taylor P., and Sine S.M. Solution NMR of acetylcholine binding protein reveals agonist-mediated conformational change of the C-loop. Mol. Pharmacol. 70 (2006) 1230-1235
22. Samochocki M., Hoffle A., Fehrenbacher A., Jostock R., Ludwig J., Christner C., et al. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 305 (2003) 1024-1036
23. Sarto-Jackson I., Ramerstorfer J., Ernst M., and Sieghart W. Identification of amino acid residues important for assembly of GABA receptor alpha1 and gamma2 subunits. J. Neurochem. 96 (2006) 983-995
24. Garcia-Colunga J., and Miledi R. Modulation of nicotinic acetylcholine receptors by strychnine. Proc. Natl Acad. Sci. USA 96 (1999) 4113-4118
25. Matsubayashi H., Alkondon M., Pereira E.F., Swanson K.L., and Albuquerque E.X. Strychnine: a potent competitive antagonist of alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal neurons. J. Pharmacol. Exp. Ther. 284 (1998) 904-913
26. Schrattenholz A., Godovac-Zimmermann J., Schafer H.J., Albuquerque E.X., and Maelicke A. Photoaffinity labeling of Torpedo acetylcholine receptor by physostigmine. Eur. J. Biochem. 216 (1993) 671-677
27. Okonjo K.O., Kuhlmann J., and Maelicke A. A second pathway of activation of the Torpedo acetylcholine receptor channel. Eur. J. Biochem. 200 (1991) 671-677
28. Hansen S.B., Sulzenbacher G., Huxford T., Marchot P., Taylor P., and Bourne Y. Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations. EMBO J. 24 (2005) 3635-3646
29. Sine S.M., and Taylor P. The relationship between agonist occupation and the permeability response of the cholinergic receptor revealed by bound cobra alpha-toxin. J. Biol. Chem. 255 (1980) 10144-10156
30. Miwa J.M., Ibanez-Tallon I., Crabtree G.W., Sanchez R., Sali A., Role L.W., and Heintz N. lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS. Neuron 23 (1999) 105-114
31. Reeves P.J., Callewaert N., Contreras R., and Khorana H.G. Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line. Proc. Natl Acad. Sci. USA 99 (2002) 13419-13424
32. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
33. Collaborative Computing Project Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallog. sect. D 50 (1994) 760-763
34. Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallog. sect. A 50 (1994) 157-163
35. McRee D. A visual protein crystallographic software system for X11/XView. J. Mol. Graph. 10 (1992) 44-46
36. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by maximum-likelihood method. Acta Crystallog. sect. D 53 (1997) 240-255
37. Unwin N. Refined structure of the nicotinic acetylcholine receptor at 4A resolution. J. Mol. Biol. 346 (2005) 967-989
38. Brejc K., van Dijk W.J., Klaassen R.V., Schuurmans M., van Der Oost J., Smit A.B., and Sixma T.K. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411 (2001) 269-276